# Hydroxyurea Treatment for Adult Sickle Cell Anemia Patients in Kinshasa

> **NCT05681598** · NA · COMPLETED · sponsor: **University of Kinshasa** · enrollment: 166 (actual)

## Conditions studied

- Sickle-Cell Anaemia

## Interventions

- **DRUG:** Hydroxyurea

## Key facts

- **NCT ID:** NCT05681598
- **Lead sponsor:** University of Kinshasa
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-30
- **Primary completion:** 2020-05-16
- **Final completion:** 2020-05-16
- **Target enrollment:** 166 (ACTUAL)
- **Last updated:** 2023-01-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05681598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05681598, "Hydroxyurea Treatment for Adult Sickle Cell Anemia Patients in Kinshasa". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05681598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*